10x Genomics Cash on Hand 2018-2026 | TXG
10x Genomics cash on hand from 2018 to 2026. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- 10x Genomics cash on hand for the quarter ending June 30, 2026 was $0.552B, a 23.43% increase year-over-year.
- 10x Genomics cash on hand for 2025 was $0.523B, a 33.05% increase from 2024.
- 10x Genomics cash on hand for 2024 was $0.393B, a 1.21% increase from 2023.
- 10x Genomics cash on hand for 2023 was $0.389B, a 10.15% decline from 2022.
|
10x Genomics Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2025 | $523 |
| 2024 | $393 |
| 2023 | $389 |
| 2022 | $433 |
| 2021 | $588 |
| 2020 | $680 |
| 2019 | $424 |
| 2018 | $65 |
|
10x Genomics Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2026-06-30 | $552 |
| 2026-03-31 | $540 |
| 2025-12-31 | $523 |
| 2025-09-30 | $482 |
| 2025-06-30 | $447 |
| 2025-03-31 | $427 |
| 2024-12-31 | $393 |
| 2024-09-30 | $398 |
| 2024-06-30 | $380 |
| 2024-03-31 | $372 |
| 2023-12-31 | $389 |
| 2023-09-30 | $357 |
| 2023-06-30 | $393 |
| 2023-03-31 | $421 |
| 2022-12-31 | $433 |
| 2022-09-30 | $453 |
| 2022-06-30 | $500 |
| 2022-03-31 | $539 |
| 2021-12-31 | $588 |
| 2021-09-30 | $600 |
| 2021-06-30 | $640 |
| 2021-03-31 | $635 |
| 2020-12-31 | $680 |
| 2020-09-30 | $828 |
| 2020-06-30 | $398 |
| 2020-03-31 | $372 |
| 2019-12-31 | $424 |
| 2018-12-31 | $65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $9.692B | $0.643B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.168B | 43.07 |
| Tempus AI (TEM) | United States | $12.423B | 0.00 |
| Hinge Health (HNGE) | United States | $7.455B | 71.62 |
| Hims & Hers Health (HIMS) | United States | $6.498B | 0.00 |
| Doximity (DOCS) | United States | $4.601B | 28.36 |
| Heartflow (HTFL) | United States | $4.202B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.688B | 243.22 |
| Privia Health (PRVA) | United States | $2.601B | 96.95 |
| Clover Health Investments (CLOV) | United States | $2.475B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.157B | 32.86 |
| Butterfly Network (BFLY) | United States | $2.077B | 0.00 |
| Schrodinger (SDGR) | United States | $1.716B | 0.00 |
| Omnicell (OMCL) | United States | $1.484B | 21.19 |
| Azenta (AZTA) | United States | $1.447B | 78.64 |
| Enovis (ENOV) | United States | $1.035B | 5.36 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.668B | 0.00 |
| Phreesia (PHR) | United States | $0.642B | 34.50 |
| Claritev (CTEV) | United States | $0.602B | 0.00 |
| Veradigm (MDRX) | United States | $0.594B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.416B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.371B | 0.00 |
| CapsoVision (CV) | United States | $0.319B | 0.00 |
| Standard BioTools (LAB) | United States | $0.271B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.145B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.132B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 6.41 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.064B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.051B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| HeartSciences (HSCS) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.005B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |